These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Emergence of Norovirus GII.4 variants in acute gastroenteritis outbreaks in South Korea between 2006 and 2013. Cho HG; Park PH; Lee SG; Kim JE; Kim KA; Lee HK; Park EM; Park MK; Jung SY; Lee DY; Yoon MH; Lee JB; Paik SY J Clin Virol; 2015 Nov; 72():11-5. PubMed ID: 26356986 [TBL] [Abstract][Full Text] [Related]
16. Duration of immunity to norovirus gastroenteritis. Simmons K; Gambhir M; Leon J; Lopman B Emerg Infect Dis; 2013 Aug; 19(8):1260-7. PubMed ID: 23876612 [TBL] [Abstract][Full Text] [Related]
17. [Epidemic and control strategy on nosocomial outbreak of norovirus gastroenteritis]. Xu Q Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Oct; 30(5):614-7. PubMed ID: 19024398 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the homo- and heterotypic immune responses after natural norovirus infection. Rockx B; Baric RS; de Grijs I; Duizer E; Koopmans MP J Med Virol; 2005 Nov; 77(3):439-46. PubMed ID: 16173019 [TBL] [Abstract][Full Text] [Related]
19. Molecular chaperone Hsp90 is a therapeutic target for noroviruses. Vashist S; Urena L; Gonzalez-Hernandez MB; Choi J; de Rougemont A; Rocha-Pereira J; Neyts J; Hwang S; Wobus CE; Goodfellow I J Virol; 2015 Jun; 89(12):6352-63. PubMed ID: 25855731 [TBL] [Abstract][Full Text] [Related]
20. Identification of Antinorovirus Genes in Human Cells Using Genome-Wide CRISPR Activation Screening. Orchard RC; Sullender ME; Dunlap BF; Balce DR; Doench JG; Virgin HW J Virol; 2019 Jan; 93(1):. PubMed ID: 30305350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]